ETRAVAMO Trademark

Trademark Overview

On Thursday, June 27, 2019, a trademark application was filed for ETRAVAMO with the United States Patent and Trademark Office. The USPTO has given the ETRAVAMO trademark a serial number of 88491688. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Wednesday, September 4, 2024. This trademark is owned by Arena Pharmaceuticals, Inc.. The ETRAVAMO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases
etravamo

General Information

Serial Number88491688
Word MarkETRAVAMO
Filing DateThursday, June 27, 2019
Status711 - CANCELLED - SECTION 7
Status DateWednesday, September 4, 2024
Registration Number7093814
Registration DateTuesday, June 27, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateWednesday, September 4, 2024
Primary Code005
First Use Anywhere DateThursday, October 20, 2022
First Use In Commerce DateThursday, October 20, 2022

Trademark Owner History

Party NameArena Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NameArena Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NameArena Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, November 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 13, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Saturday, August 31, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 19, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 4, 2024CANCELLED SECTION 7-TOTAL
Thursday, January 25, 2024REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Monday, December 14, 2020SOU TEAS EXTENSION RECEIVED
Monday, May 24, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 23, 2021SOU TEAS EXTENSION RECEIVED
Thursday, June 2, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 31, 2022SOU TEAS EXTENSION RECEIVED
Monday, May 1, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, January 25, 2024TEAS SECTION 7 SURRENDER RECEIVED
Friday, May 19, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 23, 2019NON-FINAL ACTION WRITTEN
Thursday, March 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 16, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 1, 2019NEW APPLICATION ENTERED
Monday, July 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Monday, May 1, 2023USE AMENDMENT FILED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, May 20, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 2, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020SOU EXTENSION 1 FILED
Monday, May 24, 2021SOU EXTENSION 2 FILED
Tuesday, November 23, 2021SOU EXTENSION 3 FILED
Monday, October 31, 2022SOU EXTENSION 5 FILED
Monday, December 14, 2020SOU EXTENSION 1 GRANTED
Thursday, March 19, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, March 19, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 23, 2019NON-FINAL ACTION E-MAILED
Tuesday, June 27, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, March 19, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, August 1, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 3 GRANTED
Thursday, June 2, 2022SOU EXTENSION 4 GRANTED
Monday, November 7, 2022SOU EXTENSION 5 GRANTED
Tuesday, January 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 8, 2019ASSIGNED TO LIE
Wednesday, September 18, 2019ASSIGNED TO EXAMINER
Thursday, June 2, 2022SOU EXTENSION 4 FILED
Monday, May 24, 2021SOU EXTENSION 2 GRANTED
Monday, September 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 27, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 4, 2024NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED

Related Keywords

etravamo diseases disease crohn irritable bowel autoimmune syndrome tract disorders human